Goldman Sachs Group Inc Arcellx, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 299,259 shares of ACLX stock, worth $22.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

299,259

Previous 258,167 15.92%

Holding current value

$22.6 Million

Previous $14.2 Million 75.4%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$50.91 - $86.61 $2.09 Million - $3.56 Million	41,092 Added 15.92%	299,259 $25 Million
Q2 2024 Aug 13, 2024	SELL	$49.74 - $66.98 $727,497 - $979,649	-14,626 Reduced 5.36%	258,167 $14.2 Million
Q1 2024 May 15, 2024	SELL	$51.85 - $73.49 $4.3 Million - $6.09 Million	-82,900 Reduced 23.31%	272,793 $19 Million
Q4 2023 Feb 13, 2024	SELL	$31.75 - $57.99 $16.5 Million - $30.1 Million	-519,165 Reduced 59.34%	355,693 $19.7 Million
Q3 2023 May 14, 2024	BUY	$31.51 - $37.4 $16.4 Million - $19.4 Million	519,165 Added 145.96%	874,858 $31.4 Million
Q3 2023 Nov 14, 2023	SELL	$31.51 - $37.4 $4.54 Million - $5.39 Million	-144,056 Reduced 14.14%	874,858 $31.4 Million
Q2 2023 May 14, 2024	SELL	$27.49 - $46.9 $6.92 Million - $11.8 Million	-251,812 Reduced 19.82%	1,018,914 $32.2 Million
Q2 2023 Aug 14, 2023	SELL	$27.49 - $46.9 $6.92 Million - $11.8 Million	-251,812 Reduced 19.82%	1,018,914 $32.2 Million
Q1 2023 May 14, 2024	BUY	$26.92 - $33.94 $30.9 Million - $39 Million	1,148,609 Added 940.58%	1,270,726 $39.2 Million
Q1 2023 May 11, 2023	BUY	$26.92 - $33.94 $30.9 Million - $39 Million	1,148,609 Added 940.58%	1,270,726 $39.2 Million
Q4 2022 May 14, 2024	BUY	$17.18 - $33.0 $583,054 - $1.12 Million	33,938 Added 38.49%	122,117 $3.78 Million
Q4 2022 Feb 13, 2023	BUY	$17.18 - $33.0 $583,054 - $1.12 Million	33,938 Added 38.49%	122,117 $3.78 Million
Q3 2022 May 14, 2024	SELL	$16.67 - $22.04 $4.46 Million - $5.9 Million	-267,514 Reduced 75.21%	88,179 $1.66 Million
Q3 2022 Nov 10, 2022	BUY	$16.67 - $22.04 $1.47 Million - $1.94 Million	88,179 New	88,179 $0
Q2 2022 Aug 15, 2022	SELL	$7.21 - $24.43 $418,605 - $1.42 Million	-58,059 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.97 - $19.14 $753,025 - $1.11 Million	58,059 New	58,059 $814,000

Others Institutions Holding ACLX

# of Institutions

204

Shares Held

44.2M

Call Options Held

2.23M

Put Options Held

907K

View Full List

About Arcellx, Inc.

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.31B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

More about ACLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Arcellx, Inc. Transaction History